Pro-gastrin-releasing peptide as a marker for the Ewing sarcoma family of tumors.

CONCLUSIONS: Serum ProGRP levels were elevated in half of the patients with ESFTs and reflected therapeutic response. ProGRP is a reliable tumor marker for the diagnosis of ESFTs and evaluation of treatment response.
PMID: 31264078 [PubMed - as supplied by publisher]

Source: Clinical Lung Cancer - June 30, 2019 Category: Cancer & Oncology Authors: Honda Y, Katagiri H, Takahashi M, Murata H, Wasa J, Hosaka S, Ishida Y, Ito I, Muramatsu K, Mochizuki T, Matsuyama Y, Yamaguchi K Tags: Int J Clin Oncol Source Type: research